10+ years medtech development and marketing experience in EP / cardiac therapy space. Prior Sr. Product Manager at Acutus Medical. Prior engineer at Farapulse (Employee #1), Abbott, Teleflex, Access Point Technologies, Freudenberg.

Serial medtech entrepreneur and operator who has sourced over $200M of startup capital and has over $1B of exits across three deals in the medical device industry Co-Founder Farapulse acquired for $800M+ by Boston Scientific (NYSE: BSX). Co-Founder/CFO of Attune Medical acquired by Haemonetics (NYSE: HAE) for $160M up-front plus uncapped 3-year revenue earnout. Prior CFO at SIA acquired for up to $140M by Integra LifeSciences (NASDAQ: IART).

Practicing cardiac electrophysiology physician at Scripps (San Diego, CA) and serial medtech entrepreneur. Prior executive at Acutus (NYSE: AFIB). Co-Founder and Inventor of Farapulse acquired for $800M+ by Boston Sci (NYSE: BSX).

Charles brings over 20 years of medical device regulatory and quality experience, has secured cardiovascular device approvals in U.S., Europe, and Japan and has successfully supported FDA and other regulatory body audits. Previously, Charles worked with Blockade Medical (acquired by Balt in 2016), Ablation Frontiers (acquired by Medtronic for up to $225M), and Edwards Lifesciences. Charles received a B.S. in Bioengineering at UCSD.

20 years of medical device experience primarily in cardiac EP. Prior leadership roles at Medtronic and J&J plus experience as an early employee at several start-ups, including Ablation Frontiers, acquired in 2009 by Medtronic for $225M, and Filmetrics, acquired by KLA in 2019. Jay holds a Bioengineering degree from UCSD, a Master's in Biomedical Engineering from the Keck Graduate Institute, and an MBA from the Drucker School of Management.